Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience
Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health’s Feinstein Institutes for Medical Research, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Mental Health (NIMH). The five-year, multi-site clinical trial aims to significantly improve the mental health and resilience of first responders across the nation.
Feinstein Institutes Reveals Brain Changes Seen Years Before Parkinson’s Symptoms in Sleep Disorder Patients
New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in brain circuitry in people diagnosed with isolated rapid eye movement (REM) sleep behavior disorder (iRBD) years before they manifest symptoms of a degenerative brain disorder. While involuntary movements are normally inhibited during REM sleep, individuals with iRBD act out their dreams, and come to medical attention. This condition is often a precursor to progressive neurodegenerative disorders, most notably, Parkinson’s disease and a related disorder known as Lewy Body Dementia.
Feinstein Institutes Bioelectronic Medicine Scientists Develop First-of-its-Kind Wireless Neuromodulation Device for Research
Engineers and researchers in the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research have developed a novel fully-implantable wireless bidirectional vagus nerve stimulation (VNS) and sensing device for mice. Details about the device and its capabilities, published in the journal Biosensors and Bioelectronics, outline the potential to transform how bioelectronic medicine research is conducted in labs worldwide.
